Panel Discussion
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD